Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Osiris Therapeutics (OSIR) strengthens Management Team

OSIR has appointed Stephen Potter as SVP of operations and corporate development, reporting directly to Randal Mills, President and CEO.

Mr. Potter has more than 20 years of life science management experience, most recently as SVP of Corporate and Business Development at Genzyme Corporation (GENZ).

  • During his more than 10 years at GENZ, Stephen led a team responsible for providing strategic and transactional direction to GENZ’s business units. Prior to Genzyme, he was SVP of Business Development for DuPont’s Pharmaceutical subsidiary in Wilmington, Delaware.

The Bottom Line: He brings over a decade of real-world cell therapy and biopharmaceutical experience and his mission is to direct approval of OSIR’s stem cell therapies.